Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
235.001074735
InChI
InChI=1S/C3H11NO7P2/c4-2-1-3(5,12(6,7)8)13(9,10)11/h5H,1-2,4H2,(H2,6,7,8)(H2,9,10,11)
InChI Key
InChIKey=WRUUGTRCQOWXEG-UHFFFAOYSA-N
IUPAC Name
(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid
Traditional IUPAC Name
3-amino-1-hydroxy-1-phosphonopropylphosphonic acid
SMILES
NCCC(O)(P(O)(O)=O)P(O)(O)=O
pKa (strongest acidic)
0.67
pKa (Strongest Basic)
9.86
Refractivity
42.62 m3·mol-1
Dược Lực Học :
Pamidronate is in a class of drugs called bisphosphonates. Pamidronate reduces breakdown of the bones. Pamidronate is used in the treatment of Paget's disease of bone; to reduce high levels of calcium in the blood associated with malignancy (cancer); and to reduce the breakdown of bone due to metastases of breast cancer or multiple myeloma.
Cơ Chế Tác Dụng :
Pamidronic acid (INN) or pamidronate disodium (USAN), marketed as pamidronate disodium pentahydrate under the brand name Aredia, is a bisphosphonate. [Wikipedia]
The mechanism of action of pamidronate is inhibition of bone resorption. Pamidronate adsorbs to calcium phosphate (hydroxyapatite) crystals in bone and may directly block dissolution of this mineral component of bone. In vitro studies also suggest that inhibition of osteoclast activity contributes to inhibition of bone resorption. Pamidronate also targets farnesyl pyrophosphate (FPP) synthase. Nitrogen-containing bisphosphonates (such as pamidronate, alendronate, risedronate, ibandronate and zoledronate) appear to act as analogues of isoprenoid diphosphate lipids, thereby inhibiting FPP synthase, an enzyme in the mevalonate pathway. Inhibition of this enzyme in osteoclasts prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are essential for the post-translational farnesylation and geranylgeranylation of small GTPase signalling proteins. This activity inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass.
Dược Động Học :
▧ Absorption :
Plasma concentration rises rapidly upon IV administration.
▧ Protein binding :
Approximately 54% to human serum proteins.
▧ Metabolism :
Pamidronate is not metabolized and is exclusively eliminated by renal excretion
▧ Route of Elimination :
Pamidronate is not metabolized and is exclusively eliminated by renal excretion.
▧ Half Life :
The mean ± SD elimination half-life is 28 ± 7 hours
▧ Clearance :
* 107 +/- 50 mlL/min
Độc Tính :
Side effects include an allergic reaction, kidney problems, seizures, low levels of calcium, magnesium, or phosphorus in the blood
Chỉ Định :
For the treatment of moderate or severe hypercalcemia associated with malignancy
Liều Lượng & Cách Dùng :
Injection, powder, lyophilized, for solution - Intravenous - 30 mg/vial
Injection, powder, lyophilized, for solution - Intravenous - 60 mg/vial
Injection, solution - Intravenous - 3 mg/ml
Injection, solution - Intravenous - 6 mg/ml
Injection, solution - Intravenous - 9 mg/ml
Dữ Kiện Thương Mại
Giá thị trường
-
Giá bán buôn : USD >86.09
Đơn vị tính : vial
-
Giá bán buôn : USD >86.09
Đơn vị tính : vial
-
Giá bán buôn : USD >111.94
Đơn vị tính : each
-
Giá bán buôn : USD >129.14
Đơn vị tính : vial
-
Giá bán buôn : USD >182.69
Đơn vị tính : vial
-
Giá bán buôn : USD >258.28
Đơn vị tính : vial
-
Giá bán buôn : USD >258.28
Đơn vị tính : vial
-
Giá bán buôn : USD >258.28
Đơn vị tính : vial
-
Giá bán buôn : USD >279.86
Đơn vị tính : each
-
Giá bán buôn : USD >548.05
Đơn vị tính : vial
-
Giá bán buôn : USD >755.64
Đơn vị tính : each
-
Giá bán buôn : USD >839.59
Đơn vị tính : each
Nhà Sản Xuất
-
Sản phẩm biệt dược : Aminomux
-
Sản phẩm biệt dược : Aredia
-
Sản phẩm biệt dược : Pamimed
Tài Liệu Tham Khảo Thêm
National Drug Code Directory